Cancer Type-Specific Gene Panels For Solid Tumors
While many cancer types have some gene mutations in common, most genetic alterations tend to occur primarily in one cancer type. Certain gene variants offer stronger predictive power and more applicable treatment-related information in specific cancer types.
We offer a spectrum of panels tailored to specific types of cancers to provide critical information on genetic biomarkers and treatment options, potential resistance mechanisms, risk stratification and more to fit your personal needs.
LUNG CANCER
TETRADECAN™ (14-gene, lung cancer)
PULMOCAN™ (139-gene, lung cancer)
VANGUARD™ (139-gene, lung cancer)
BREAST AND GYNECOLOGIC CANCERS
MAMECAN™ (68-gene, breast cancer)
GYNOCAN™ (70-gene, gynecologic cancer)
UROLOGIC CANCERS
PROSCAN™ (80-gene, prostate cancer)
UROCAN™ (61-gene, bladder and renal cancers)
GASTROINTESTINAL CANCERS
STOMOCAN™ (60-gene, gastric cancer)
ESOPHACAN™ (58-gene, esophageal cancer)
PANCRECAN™ (56-gene, pancreatic cancer)
LIVOCAN™ (59-gene, liver cancer and CCA)
GISTCAN™ (47-gene, gastrointestinal stromal tumor, GIST)
INTESCAN™ (52-gene, colorectal and small intestine cancers)
CENTRAL NERVOUS SYSTEM CANCERS
NEUROPRO™ (616-gene, CNS tumors)
NEUROCAN™ (106-gene, CNS classification/grading)
GLIOCAN™ (12 key biomarkers, glioma)
SARCOMAS
SARCOPACT™ (627-gene, soft tissue and bone tumors)
SARCORNA™ (201-gene, soft tissue and bone tumors, targeted RNA-sequencing for fusion detection)
OTHER TUMORS
MELACAN™ (52-gene, melanoma)
THYROCAN™ (54-gene, thyroid cancer)
Retinoblastoma genetic testing (RB1, whole exons, splicing sites and promoter, copy number variation and mosaic mutations)
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.
